Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | LOC100134331///LOC100126583///LOC652128///VSIG6///IGHV4-31///IGHM///IGHG4///IGHG3///IGHG1///IGHD///IGHA2///IGHA1///IGH@ |
| Upstream (Parents) |
|---|
| (<<) KIAA1659///MKL1///COX6B1P3 → LOC100134331///LOC100126583///LOC652128///VSIG6///IGHV4-31///IGHM///IGHG4///IGHG3///IGHG1///IGHD///IGHA2///IGHA1///IGH@ |
| (<<) ZIC4 → LOC100134331///LOC100126583///LOC652128///VSIG6///IGHV4-31///IGHM///IGHG4///IGHG3///IGHG1///IGHD///IGHA2///IGHA1///IGH@ |
| (<<) GBX2 → LOC100134331///LOC100126583///LOC652128///VSIG6///IGHV4-31///IGHM///IGHG4///IGHG3///IGHG1///IGHD///IGHA2///IGHA1///IGH@ |
| (<<) PKNOX2 → LOC100134331///LOC100126583///LOC652128///VSIG6///IGHV4-31///IGHM///IGHG4///IGHG3///IGHG1///IGHD///IGHA2///IGHA1///IGH@ |
| (<<) NODAL → LOC100134331///LOC100126583///LOC652128///VSIG6///IGHV4-31///IGHM///IGHG4///IGHG3///IGHG1///IGHD///IGHA2///IGHA1///IGH@ |
| (<<) TNFSF11 → LOC100134331///LOC100126583///LOC652128///VSIG6///IGHV4-31///IGHM///IGHG4///IGHG3///IGHG1///IGHD///IGHA2///IGHA1///IGH@ |
| (<<) LOC729991-MEF2B → LOC100134331///LOC100126583///LOC652128///VSIG6///IGHV4-31///IGHM///IGHG4///IGHG3///IGHG1///IGHD///IGHA2///IGHA1///IGH@ |
| (<<) LLGL1 → LOC100134331///LOC100126583///LOC652128///VSIG6///IGHV4-31///IGHM///IGHG4///IGHG3///IGHG1///IGHD///IGHA2///IGHA1///IGH@ |
| (<<) RPL5P1///RPL5P34///RPL5 → LOC100134331///LOC100126583///LOC652128///VSIG6///IGHV4-31///IGHM///IGHG4///IGHG3///IGHG1///IGHD///IGHA2///IGHA1///IGH@ |
| (<<) THOC5 → LOC100134331///LOC100126583///LOC652128///VSIG6///IGHV4-31///IGHM///IGHG4///IGHG3///IGHG1///IGHD///IGHA2///IGHA1///IGH@ |
| Downstream (Children) |
|---|
| LOC100134331///LOC100126583///LOC652128///VSIG6///IGHV4-31///IGHM///IGHG4///IGHG3///IGHG1///IGHD///IGHA2///IGHA1///IGH@ → KIAA1659///MKL1///COX6B1P3 (>>) |
